TARA Protara Therapeutics, Inc.: institutional ownership and insider trading
121 funds reported holding $216M of Protara Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $3.17M, with 24 new positions and 18 funds selling out; over the last 12 months insiders bought $0 and sold $1.01M on the open market.
TARA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$21.7M, EPS -0.36
- Quarter ended Mar 31, 2026: revenue n/a, net income −$17.8M, EPS -0.31
- Quarter ended Dec 31, 2025: revenue n/a, net income −$17.3M, EPS -0.39
- Quarter ended Sep 30, 2025: revenue n/a, net income −$13.3M, EPS -0.31
Famous investors holding TARA
- Izzy Englander (Millennium Management): $11.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $4.71M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $961K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $266K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $42.5K, 0.0% of the portfolio
Largest institutional holders of TARA
- JANUS HENDERSON GROUP PLC (JHG) — $27.2M
- Jupiter Topco LLC — $17.9M
- BlackRock, Inc. (BLK) — $14.0M
- VANGUARD GROUP INC — $12.7M
- MILLENNIUM MANAGEMENT LLC — $11.8M
- Velan Capital Investment Management LP — $10.9M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.79M
- Blackstone Inc. (BX) — $8.65M
- ORBIMED ADVISORS LLC — $8.48M
- Sio Capital Management, LLC — $7.34M
Recent TARA insider trades
- Jun 29, 2026: Shefferman Jesse sold 215,687 shares ($882K)
- Apr 8, 2026: Zummo Jacqueline sold 1,134 shares ($6.12K)
- Apr 1, 2026: Zummo Jacqueline sold 22,598 shares ($119K)
- May 14, 2025: Levy Richard S bought 20,000 shares ($63.8K)
5%+ owners
- JANUS HENDERSON GROUP PLC: 9.6% (Schedule 13G/A, filed May 15, 2026)
- JANUS HENDERSON GROUP Ltd.: 8.4% (Schedule 13G/A, filed Aug 13, 2026)
- BlackRock, Inc.: 6.3% (Schedule 13G, filed Apr 27, 2026)
- Millennium Management LLC: 5.7% (Schedule 13G/A, filed Jul 7, 2026)